Award
National Cancer Institute 5R35CA210087-09
Human natural killer cells: Advancing biology and clinical applications
Recipient
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
Award Amount
$886,438.00
Ceiling
$886,438.00
Awarded
July 28, 2026
Identifier
5R35CA210087-09
Research grant awarded by the National Cancer Institute to advance the biology and clinical applications of human natural killer cells, focusing on NK cell-based therapies and clinical translation.
Description
This is a research grant opportunity from the National Cancer Institute for studies on natural killer (NK) cells, including their biology, clinical applications, and potential for cancer therapy. The project involves advancing NK cell-based therapies, including CAR NK cells, and translating findings into clinical trials.